 WALL, N.J., Nov. 19, 2020 GLOBE NEWSWIRE -- BIO-key International, Inc. Nasdaq: BKYI, an innovative provider of biometric and other multi-factor identity and access management IAM solutions for strong, convenient authentication and large-scale identity applications, today announced that the Companys Board of Directors has approved a 1-for-8 reverse stock split that is expected to become effective on November 20, 2020. On November 16th, BIO-key shareholders approved an amendment to the Companys Certificate of Incorporation to effect a reverse split at a ratio between 1-for-4 and 1-for-10, with the final ratio determined by the Companys Board of Directors. Pursuant to the reverse split, BIO-key shareholders will receive one 1 new share of common stock for every eight 8 shares held prior to the effective date. Any fractional shares will be rounded up to the next whole share and shareholders will not receive cash in lieu of any such fractional shares. BIO-key expects to commence trading on the Nasdaq Capital Market on a split-adjusted basis on November 20, 2020. 